pivka-ii Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Interventional (1)

Korea University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadencephalopathy

I am/have/hadascites

I am/have/hadearly detection

I am/have/hadcarcinoma

I am/have/hadct scan

I am/have/hadvaricose veins

I am/have/hadhepatic decompensation

I am/have/hadliver transplant

I am/have/hadfibrosis

I am/have/hadjaundice

I am/have/hadcirrhosis

I am/have/hadcancer

I am/have/hadhepatocellular carcinoma

I am/have/hadhypoalbuminemia

I am/have/hadthrombocytopenia

I am/have/hadgastric varices

I am/have/hadearly diagnosis

I am/have/hadstiffness

added new label for I am/have/had

more

I am looking for

I am looking fordes-gamma-carboxy prothrombin

I am looking forwarfarin

I am looking forapri

I am looking forpivka-ii

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 1000s
Interventional Study
all
Endocrinology
Recruiting

Combining Biomarkers (AFP AFP-L3 and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

In this study, three biomarkers tests (AFP, AFP-L3 and PIVKA-II) and abdominal sonography or CT scans are performed every 6 months to detect hepatocellular carcinoma (HCC) early in patients with cirrhosis, a high-risk group of HCC.

encephalopathy

ascites

early detection

des-gamma-carboxy prothrombin

carcinoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.